vs
Side-by-side financial comparison of Elme Communities (ELME) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
Elme Communities is the larger business by last-quarter revenue ($62.1M vs $39.6M, roughly 1.6× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -198.9%, a 234.8% gap on every dollar of revenue. On growth, Elme Communities posted the faster year-over-year revenue change (1.7% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $7.2M). Over the past eight quarters, Elme Communities's revenue compounded faster (2.7% CAGR vs -15.0%).
Elme Communities is a publicly traded U.S. real estate investment trust that primarily owns, operates and develops high-quality multifamily residential communities. It focuses on key growth markets across the U.S. Mid-Atlantic and Southeast, offering affordable to mid-tier housing options for diverse renter groups.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
ELME vs SBC — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $39.6M |
| Net Profit | $-123.5M | $14.2M |
| Gross Margin | 61.1% | 73.1% |
| Operating Margin | -183.3% | 32.5% |
| Net Margin | -198.9% | 35.9% |
| Revenue YoY | 1.7% | -10.9% |
| Net Profit YoY | -4058.7% | 117.2% |
| EPS (diluted) | $-1.40 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $39.6M | ||
| Q3 25 | $62.1M | $43.4M | ||
| Q2 25 | $62.1M | $43.4M | ||
| Q1 25 | $61.5M | $47.3M | ||
| Q4 24 | $61.3M | $44.4M | ||
| Q3 24 | $61.1M | $53.1M | ||
| Q2 24 | $60.1M | $53.1M | ||
| Q1 24 | $59.5M | $54.8M |
| Q4 25 | — | $14.2M | ||
| Q3 25 | $-123.5M | $12.8M | ||
| Q2 25 | $-3.6M | $2.5M | ||
| Q1 25 | $-4.7M | $21.5M | ||
| Q4 24 | $-3.0M | $6.5M | ||
| Q3 24 | $-3.0M | $2.8M | ||
| Q2 24 | $-3.5M | $18.5M | ||
| Q1 24 | $-3.6M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | 61.1% | 70.6% | ||
| Q2 25 | 63.5% | 69.2% | ||
| Q1 25 | 64.2% | 79.7% | ||
| Q4 24 | 62.9% | 76.3% | ||
| Q3 24 | 63.5% | 81.5% | ||
| Q2 24 | 63.4% | 74.2% | ||
| Q1 24 | 63.5% | 72.1% |
| Q4 25 | — | 32.5% | ||
| Q3 25 | -183.3% | 36.6% | ||
| Q2 25 | 9.6% | 33.6% | ||
| Q1 25 | 7.8% | 51.1% | ||
| Q4 24 | 10.4% | 10.6% | ||
| Q3 24 | 11.0% | 26.1% | ||
| Q2 24 | 9.8% | 51.4% | ||
| Q1 24 | 7.5% | 44.6% |
| Q4 25 | — | 35.9% | ||
| Q3 25 | -198.9% | 29.6% | ||
| Q2 25 | -5.7% | 5.7% | ||
| Q1 25 | -7.6% | 45.4% | ||
| Q4 24 | -4.9% | 14.7% | ||
| Q3 24 | -4.9% | 5.3% | ||
| Q2 24 | -5.8% | 34.8% | ||
| Q1 24 | -6.1% | 34.2% |
| Q4 25 | — | $0.15 | ||
| Q3 25 | $-1.40 | $0.12 | ||
| Q2 25 | $-0.04 | $0.02 | ||
| Q1 25 | $-0.05 | $0.21 | ||
| Q4 24 | $-0.04 | $0.05 | ||
| Q3 24 | $-0.03 | $0.03 | ||
| Q2 24 | $-0.04 | $0.20 | ||
| Q1 24 | $-0.04 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.1M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $908.9M | $248.3M |
| Total Assets | $1.7B | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $164.1M | ||
| Q3 25 | $7.1M | $127.4M | ||
| Q2 25 | $4.8M | $152.7M | ||
| Q1 25 | $6.4M | $132.1M | ||
| Q4 24 | $6.1M | $125.0M | ||
| Q3 24 | $4.8M | $137.4M | ||
| Q2 24 | $5.6M | — | ||
| Q1 24 | $4.2M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $248.3M | ||
| Q3 25 | $908.9M | $248.0M | ||
| Q2 25 | $1.0B | $244.6M | ||
| Q1 25 | $1.1B | $226.4M | ||
| Q4 24 | $1.1B | $195.1M | ||
| Q3 24 | $1.1B | $205.0M | ||
| Q2 24 | $1.1B | $8.8M | ||
| Q1 24 | $1.1B | $9.0M |
| Q4 25 | — | $380.4M | ||
| Q3 25 | $1.7B | $321.4M | ||
| Q2 25 | $1.8B | $315.3M | ||
| Q1 25 | $1.8B | $284.6M | ||
| Q4 24 | $1.8B | $266.1M | ||
| Q3 24 | $1.9B | $296.5M | ||
| Q2 24 | $1.9B | $19.5M | ||
| Q1 24 | $1.9B | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $15.9M | $52.0M |
| Free Cash FlowOCF − Capex | $7.2M | $51.2M |
| FCF MarginFCF / Revenue | 11.6% | 129.3% |
| Capex IntensityCapex / Revenue | 14.0% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $86.7M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $52.0M | ||
| Q3 25 | $15.9M | $-20.9M | ||
| Q2 25 | $29.8M | $-8.3M | ||
| Q1 25 | $16.2M | $1.9M | ||
| Q4 24 | $95.2M | $-7.3M | ||
| Q3 24 | $20.7M | $5.0M | ||
| Q2 24 | $28.9M | $19.2M | ||
| Q1 24 | $21.2M | $3.7M |
| Q4 25 | — | $51.2M | ||
| Q3 25 | $7.2M | $-20.9M | ||
| Q2 25 | $21.1M | $-8.6M | ||
| Q1 25 | $10.5M | $1.7M | ||
| Q4 24 | $47.9M | $-7.9M | ||
| Q3 24 | $8.8M | $4.6M | ||
| Q2 24 | $21.0M | $18.3M | ||
| Q1 24 | $7.6M | $3.0M |
| Q4 25 | — | 129.3% | ||
| Q3 25 | 11.6% | -48.3% | ||
| Q2 25 | 34.1% | -19.9% | ||
| Q1 25 | 17.1% | 3.5% | ||
| Q4 24 | 78.1% | -17.8% | ||
| Q3 24 | 14.4% | 8.7% | ||
| Q2 24 | 34.9% | 34.5% | ||
| Q1 24 | 12.8% | 5.4% |
| Q4 25 | — | 2.0% | ||
| Q3 25 | 14.0% | 0.1% | ||
| Q2 25 | 14.0% | 0.7% | ||
| Q1 25 | 9.2% | 0.5% | ||
| Q4 24 | 77.4% | 1.3% | ||
| Q3 24 | 19.4% | 0.8% | ||
| Q2 24 | 13.1% | 1.6% | ||
| Q1 24 | 22.9% | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELME
| Residential Segment | $57.7M | 93% |
| Other | $4.4M | 7% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
